JZ Capital Partners Limited JZCP
February 17, 2015 - 12:36pm EST by
zeke375
2015 2016
Price: 4.06 EPS 0 0
Shares Out. (in M): 65 P/E 0 0
Market Cap (in $M): 410 P/FCF 0 0
Net Debt (in $M): 0 EBIT 0 0
TEV (in $M): 0 TEV/EBIT 0 0

Sign up for free guest access to view investment idea with a 45 days delay.

  • United Kingdom
  • Closed-end Fund
  • Discount to NAV
  • Dividend yield
  • real estate assets
  • Private Investments
  • External Management
  • Private Equity (PE)

Description

JZ Capital Partners is an UK-listed private equity-style investment company structured as a closed-end
fund. The fund is heavily weighted towards controlled ownership of smaller private US companies,
though JZCP made a timely entry into European private company buyouts in 2010 and 2011 and has also
recently begun to build a portfolio of real estate investments in Brooklyn, New York. JZCP shares
recently traded for roughly 405 pence, or $6.25 at today’s exchange rate. The NAV per share was $10.12
as of December 31, 2014, such that the discount is nearly 40% to NAV.
 
Structure and Background
 
JZCP is domiciled in tax-friendly Guernsey in the UK and listed in London under the ticker JZCP. The
company also has a listed zero coupon preference share class (called ZDP shares) that matures in 2016
and trades under the ticker JZCN. The JZCN shares will be redeemed for 369.84 pence on June 22, 2016.
JZ’s history goes back to 1986. The predecessor vehicle to JZCP was called JZ Equity Partners (JZEP)
and was a typical private equity fund. JZCP acquired the assets of JZEP on July 1, 2008 as part of its
public share listing, which served to convert a limited-life PE fund to a permanent capital vehicle.
JZCP is advised by Jordan / Zalaznick Advisors (JZAI), which is run by Jay Jordan and David Zalaznick,
two veterans of middle market buy-outs with a nearly 40-year history of managing private equity
vehicles. Jordan and Zalaznick also each own roughly 9% of JZCP common stock. Jordan has
longstanding ties to Leucadia and was mentioned in the 2012 Leucadia annual letter that described the
history of that company. The shareholders of JZCP are also a pretty strong value group: After Jordan and
Zalaznik (about 18.5% of the shares) the major owners are Abrams Capital (nearly 20%), Leucadia
(18%), Third Avenue (8%) and Goodhaven (3%). This is a pretty good reason why there isn’t a lot of
liquidity in the stock, as these named shareholders own roughly 2/3 of the shares.
 
JZCP’s public listing really couldn’t have come at a worse time. JZCP’s stock was hit hard by the credit
crunch in late 2008 and early 2009 and JZCP found itself in the unfortunate position of having $185
million worth of preference shares coming up for redemption in June 2009 and didn’t have enough cash
to redeem it. Given that the investment portfolio was tied up largely in highly illiquid micro-cap buyouts
and high yield debt, JZCP would have had a terrible time getting enough liquidity from its portfolio
holdings to redeem the preferred shares, and the credit markets were gridlocked. It seemed that the only
options were to hold a fire sale of the company’s assets at a terrible time or try to raise additional cash and
take the dilution. The company elected to do a secondary offering in June of 2009 at a massive discount
to NAV, which of course diluted its existing investors substantially. The secondary offering was priced at
a 75% discount to the reported NAV at the time.
 
The good news was that JZCP was able to raise a substantial amount of capital - $229 million -- which
enabled the company to redeem its maturing ZDP shares, issue a new class of zero dividend preferred
shares (the current JZCN) and still have substantial cash left over. JZCP also did a reverse stock split on a
5 for 1 basis. Jay Jordan and David Zalznick each subscribed for $12.5 million worth of the new common
shares. Overall, JZCP sold 227.6 million new common shares, redeemed 29.7 million ZDP shares at par,
and issued 4.7 million new ZDP shares. Following the secondary, there were 65 million JZCP ordinary
shares. The new ZDP shares were issued at 215.8 pence at June 2009, and will be redeemed for 369.84
pence on June 22, 2016, which represented a gross yield of 8% from the date of issuance. The ZDP shares
required that JZCP maintain minimum asset coverage of at least 3 times the outstanding ZDP amount.
After the dust settled from the offering, JZCP reported that its NAV as of August 31, 2009 was $6.65 per
share, and the common shares traded at that time for $3.60, a discount of 46% to NAV.
 
Below is a comment written by Curtis Jensen, who bought 1.7 million shares in the secondary offering, in
the Third Avenue Small Cap Value Fund letter written in the summer of 2009 describing the investment:
  
London-listed JZ Capital Partners is a closed-end investment company focused on investments in,
including buyouts of, U.S. small and micro-cap companies. The Fund (Third Avenue Value) acquired
additional shares via the company’s rights offering at a fraction of the pro forma NAV. Proceeds of the
offering were used for a combination of re-financing preference shares and to expand the company’s war
chest (i.e., growth capital). Generally speaking, JZ has distinguished itself from other buyout sponsors by
using judicious amounts of leverage within its portfolio companies and by maintaining some semblance
of discipline with respect to valuation and what it’s willing to pay for acquisitions. JZ’s management
participated in the rights offering, adding to their economic interest in the company and signaling
confidence about the company’s future. At present, the portfolio boasts an enviable slug of cash following
the financing. Broadly speaking, the buyout market remains under considerable stress and many busted
deals are in need of undergoing repair work. With capital generally scarce for the small and micro-cap
companies like the ones JZ targets, it seems like a particularly good time to introduce fresh funds to a
liquidity-starved arena like the one in which JZ plays, especially if it can be done at a discount. JZ
common trades at a 40% discount to NAV as reported at June 30, 2009.
 
One can certainly consider the dilution caused by the re-cap to be a black mark against the management in
that they did not consider the possibility that the credit markets might be closed to them when they issued
debt against a portfolio of illiquid assets. On the other hand, since August 2009 JZCP’s portfolio has
performed rather well. Reported NAV has increased from $6.65 per share at August 2009 to $10.12 at
December 31, 2014, which is an increase of about 52%. In addition, JZCP has paid out about $1.35 in
dividends, for a total return of just over 70%. Also, I would note that this appreciation lags the market in
part because JZCP has not dramatically increased the internal value estimates for its private company
investments to anything close to the EBITDA multiples that the market might pay today, so I feel that
there will likely be some gains coming if JZCP sells some of its older vintage investments. As of
November 2014, JZCP was valuing its US private company portfolio at 7.4X EBITDA. JZCP’s US
portfolio of businesses generated an aggregate 17% EBITDA growth rate in the first half of FY2014
versus FY2013.
 
JZCP has appeared to be very timely in its investment activity since 2009. In early 2010, JZCP
announced the formation of a European private company buyout fund called JZ Europe Fund, and that
JZCP would co-invest in this fund (with no “double fees” to JZCP investors). JZ International is the
manager of these investments, is affiliated with JZAI, and this entity dates back to 1999 and had delivered
very impressive returns from 1999 to 2009 (roughly 32.5% annualized, according to JZCP). As a result of
this initiative, JZCP has made what appear to be some decent investments in European companies over
the last three to four years.
 
In June 2012, JZCP announced a plan designed to help reduce the discount to NAV. One of the biggest
problems for JZCP was that its legal structure capped the ownership percentage by US investors of 50%.
As part of the elimination of this restriction on US investors, JZCP moved its share listing from the LSE
to trade on the LSE’s specialist fund market (i.e., over the counter). JZCP also increased the limit on
investing in businesses outside the US to 30% of gross assets from the prior 20% limit. A final change
was a move to a defined distribution policy rather than haphazardly paying out gains each year. JZCP
now sets its dividend to pay 1.5% of NAV every six months, or 3% of NAV per year. The dividends are
paid in $USD unless the investor elects to receive sterling. Given the current 40% discount to NAV, this
means that investors will get about a 5% yield at the current price.
 
Beginning in late 2013, JZCP began to partner with a real estate investing firm to make investments in
real estate with “value-added” conversion or build-out potential. Almost all of these investments thus far
have been made in Brooklyn, New York. As of mid-2014, JZCP’s real estate portfolio consisted of 22
properties in Brooklyn with a total capitalization of $460M, of which JZCP held $126M in equity. Most
of these are in and around the up-and-coming areas close to the new Barclays Center, which is where the
Brooklyn Nets play. JZCP has since made additional investments in Brooklyn and recently announced its
first real estate investment outside of Brooklyn, that being in Miami.
 
In mid 2014, JZCP began to look towards the redemption of its zero-coupon preferred securities that
come due in mid-2016. JZCP raised $68M from the sale of a new “convertible unsecured loan stock” or
CULS that yields 6%, mature in seven years and convert at a price of roughly $9.28, which was a slight
premium to NAV at the time.
 
The Current Portfolio
 
As of November 30, 2014, JZCP’s portfolio consisted of 40 US micro-cap company buyouts valued at
$370M, or about 41% of the investment portfolio. There were 11 European micro-cap investments,
valued at $217M, or 24% of the total portfolio. The real estate portfolio was worth about $153M, while
other private investments were $66.5M. All told 89% of the portfolio is in private investments. JZCP
also has some listed investments, including about $15M in corporate debt, $11M in bank debt, about
$40M in UK gilts, and $34M in cash. The total portfolio was valued at $906M, and there was about
$243M in total debt (ZDPs, CULs, and a $50M loan facility with Jeffries). NAV was $663M.
JZCP’s US private investment portfolio is divided into five industry verticals, each of which is run by a
senior buy-out executive / operator. JZCP’s October 2014 presentation showed TTM revenue and
EBITDA by vertical through the first half of 2014. The largest vertical is Industrial ($220.8M revenue and
$34.5M EBITDA), followed by Testing ($112M revenue and $14M EBITDA). Other verticals are water,
healthcare, and logistics. Altogether, the five verticals totaled $462M in revenue and $68.9M in EBITDA
for the TTM period. More information on the company’s investment portfolio is available on the
company’s website and there are good profiles of the European companies at JZI Europe’s website:
 
http://jzcp.com/home
http://www.jzieurope.com/
 
Fees and Risk Factors
 
As mentioned above, JZCP is externally managed with a fee structure comparable to that of most U.S.
traded BDCs. The management fee is 0.375% per quarter (1.5% annually) on gross assets, along with an
income fee of 20% of the amount of net investment income exceeding 2% per quarter (or 8% annualized).
The advisor then receives 100% of the income between 2% and 2.5% per quarter, and then 20% of any
incremental income beyond that point. In addition, there is a 20% carry on any capital gains net of capital
losses with a high water mark based on cumulative gains and losses from inception. The fees are a little
high in my opinion.
 
Among the risk factors with JZAI are the potential conflicts of interest and lack of full attention to JZCP
investments due to several other investing funds that Jordan and Zalaznick are involved in. JZAI is
affiliated with two large U.S. private equity fund advisors. The first is Bolder Capital, a multi-billion shop
engaged in the typical private equity activities of sourcing, buying, and operating businesses in
partnership with the existing company management. JZCP invests in ideas sourced by Bolder Capital
through a 50/50 joint venture between JZCP and The Edgewater Funds, one of the vehicles managed by
Bolder. The other affiliated management firm is The Jordan Company, which is a New York-based
private investment firm also owned by Jordan and Zalaznik, through which JZAI manages its US based
investments. Then there is the non-US oriented JZ International, which is where JZCP sources its non-
US investments. In all of these cases, JZCP appears to co-invest with these entities on fair terms, but
there is some potential for conflict of interest with so many vehicles vying for investment opportunities.
 
 
 
As for leverage, JZCP typically does not carry a lot of leverage on its micro-cap portfolio companies,
usually averaging debt senior to JZ of less than 2 turns of EBITDA. The reported portfolio leverage has gone
up lately, likely due to the easy access to capital. Regardless, the company should have plenty of liquid
assets to redeem its zero coupon preferred shares in 2016 and the maturity should lower JZCP’s borrow
costs as it taps lower cost sources of credit, such as the new CULs.
 
There is one recent negative piece of news to mention, though I don’t believe it is a meaningful indicator,
and that is that one of the two principals of JZCP’s investment advisor, David Zalaznick, sold 1.716M
shares in late November for £4 per share. Following this sale, Zalaznick owns over 6M shares or 9.23%
of the total outstanding. I have no insight into what would motivate this sale, but I don’t think it
represents any kind of impending trouble.
 
JZCP also recently announced that it would be recommending changes to the company’s investment policy to
allow for more flexibility in buying opportunities, including allowing for more real estate and European
investments, which are currently limited by the existing policy. JZCP notes that it considers the
opportunities for “micro-cap businesses” in the US to be expensive and a “seller’s market” but sees
attractive opportunities in Western European private companies and in real estate. However, the company
will continue to manage a diversified portfolio across its areas of expertise, including small company buy-
outs, real estate, and occasional mezzanine and distressed debt opportunities.
 
Valuation and Summary
 
Despite strong performance coming out of the financial crisis, JZCP’s stock now trades at nearly the same
discount to NAV that it traded at following its recap in late 2009, despite an attractive investment
portfolio and several years of good results. The recent insider sale notwithstanding, I can see no reason
for the stock’s deep discount. Buying a portfolio of PE investments run by a seasoned manager with a
very strong long-term track record and a 5% dividend yield at about 60 cents on the dollar seems like a
decent proposition. JZCP values its private equity portfolio at roughly 7.5X EBITDA; at the current
discount, we are paying about 4.5X. I would very much expect to see further realizations in the US
private equity portfolio given the “seller’s market” and would expect to see some further NAV per share
accretion as a result. I also expect that JZCP’s European investments, most made in the 2010-2012 time
period, will do rather well. Finally, the real estate investments in Brooklyn have probably picked up some
value already and I am not against having this exposure given the price we are paying. Though I have no
reason to believe that the stock market will get excited about JZCP in the near term, there are three ways
for us to win: 1) NAV continues to grow over time; 2) discount to NAV narrows for some reason; 3) we
continue to get paid a decent yield while we wait. There is a possibility that one of the large value
shareholders may begin to clamor for more aggressive policies designed to close the discount. Overall, I
find JZCP to be an attractive investment.  If I could buy the whole portfolio at today's quoted market price, I 
wouldn't hesitate to do so.
 
 
 
 
 
 
 
 
 

 

I do not hold a position with the issuer such as employment, directorship, or consultancy.
I and/or others I advise hold a material investment in the issuer's securities.

Catalyst

Possible catalysts are: 1) NAV grows over time as JZ sells some of its US control businesses at good prices; 2) discount to NAV narrows to something more reasonable, like 20-25%; 3) JZCP management takes some aggressive action to reduce the discount; or 4) large investors pressure some kind of action to reduce the discount. 

    show   sort by    
      Back to top